← All trials
NCT03270787
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 24, 2016
- Primary completion
- Jul 13, 2016
- Completion date
- Jul 13, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 58
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tasly Pharmaceuticals, Inc.Lead sponsor
- Tasly Pharmaceuticals, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.